Stay updated on Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Sign up to get notified when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.
Latest website image capture
Clouds background image

Latest updates to the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    - The page's revision label has been updated from v3.5.3 to v3.5.4. - This signals a minor site version update that affects rendering but not the study data.
    Difference
    0.0%
    Check dated 2026-05-17T10:01:16.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page footer was updated to reflect a new site revision number, moving from v3.5.2 to v3.5.3. This represents an update to the ClinicalTrials.gov page software version rather than any change to the clinical trial details.
    Difference
    0.0%
    Check dated 2026-04-25T18:40:33.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a minor version bump with no changes to study content or interactions.
    Difference
    0.0%
    Check dated 2026-04-18T13:37:03.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T01:06:06.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:41:20.000Z thumbnail image
  9. Check
    112 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:37:29.000Z thumbnail image

Stay in the know with updates to Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Enter your email address, and we'll notify you when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.